AU Patent

AU2011327113B2 — Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same

Assigned to Shionogi and Co Ltd · Expires 2015-06-25 · 11y expired

What this patent protects

The present invention provides a compound represented by Formula (IA): an acid addition salt thereof, and/or stable crystals of solvates thereof. The crystals are extremely useful as an active ingredient for producing pharmaceutical products. The present invention further provide…

USPTO Abstract

The present invention provides a compound represented by Formula (IA): an acid addition salt thereof, and/or stable crystals of solvates thereof. The crystals are extremely useful as an active ingredient for producing pharmaceutical products. The present invention further provides a novel method for producing a 6,7-unsaturated-7-carbamoyl morphinane derivative.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011327113B2
Jurisdiction
AU
Classification
—
Expires
2015-06-25
Drug substance claim
No
Drug product claim
No
Assignee
Shionogi and Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.